On 10/8/24, PTC Therapeutics Inc (NASDAQ: PTCT) stock enjoyed a major increase of 16.5%, closing at $40.77. Moreover, this advance was accompanied by exceptionally high trading volume at 371% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 9.9% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, PTCT is expected to be a major Value Eraser.
PTC Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment